The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Intestinal Transport of β-Lactam Antibiotics: Analysis of the Affinity at the H+/Peptide Symporter (PEPT1), the Uptake into Caco-2 Cell Monolayers and the Transepithelial Flux
Abstract
Purpose This study on the intestinal transport of beta-lactam antibiotics was undertaken to investigate the correlation between cellular transport parameters and the bioavailability. Methods Transport of 23 beta-lactam antibiotics was characterized by measuring their ability to inhibit the uptake of glycylsarcosine into Caco-2 cells, their uptake into the cells and their total flux across the cell monolayers. Results Ceftibuten and cyclacillin were recognized by PEPT1 with affinity constants comparable to those of natural dipeptides (K(i) = 0.3 and 0.5 mM, respectively). Cefadroxil, cefamandole, cephradine, cefaclor, cefuroxime-axetil, cefixime, cephalotin, cephalexin and ampicillin also interacted with PEPTI (K(i) = 7-14 mM). In contrast, cefapirin, cefodizime, cefuroxime, cefmetazole, ceftazidime, benzyl-penicillin, ceftriaxone, cefpirome, cefotaxime, cefepime, cephaloridine and cefsulodin displayed no affinity to the transport system (K(i) > 20 mM). The uptake into the cells and the transepithelial flux was highest for those beta-lactam antibiotics, which showed the strongest inhibition of [14C]Gly-Sar transport (p Conclusions The probability of oral bioavailability for beta-lactam antibiotics is mainly determined by their affinity to PEPTI. A threshold K(i) value of 14 mM with respect to Gly-Sar uptake is required.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Delie, F., & Rubas, W. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i3.20 · Cited by 440
The oligopeptide transporter (Pept-1) in human intestine: Biology and function
Adibi, S. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70112-4 · Cited by 351
Peptide Transporters in the Intestine and the Kidney
Leibach, F. H., & Ganapathy, V. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.000531 · Cited by 315
Antibiotika-Therapie in Klinik und Praxis
Simon, C., Stille, W., Wiedemann, H.-R., & Siede, W. (1970) · F. K. Schattauer eBooks · Cited by 313
Ganapathy, M. E., Brandsch, M., Prasad, P. D., Ganapathy, V., & Leibach, F. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25672 · Cited by 274
Self-citationCommon characteristics for Na+-dependent sugar transport in Caco-2 cells and human fetal colon
Blais, A., Bissonnette, P., & Berteloot, A. (1987) · The Journal of Membrane Biology · doi:10.1007/bf01871231 · Cited by 195
Brandsch, M., Miyamoto, Y., Ganapathy, V., & Leibach, F. H. (1994) · Biochemical Journal · doi:10.1042/bj2990253 · Cited by 153
Self-citationRecognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1cells
Terada, T., Saito, H., Mukai, M., & Inui, K. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.5.f706 · Cited by 129
(D) Routes of delivery: Case studies
Smith, P. L., Wall, D. A., Gochoco, C. H., & Wilson, G. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90005-b · Cited by 104
Function and Molecular Structure of Brush Border Membrane Peptide/H+ Symporters
Daniel, H. (1996) · The Journal of Membrane Biology · doi:10.1007/s002329900144 · Cited by 99
Research works printed but not linked: 1
- A. Tsuji. Intestinal absorption of β-lactam antibiotics. In M. D. Taylor and G. L. Amidon (eds.) Peptide-based drug design. American Chemical Society, Washington, DC., 1995, pp. 101–134.
Cited by
Prediction of Drug Absorption Using Multivariate Statistics
Egan, W. J., Merz, & Baldwin, J. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000292e · Cited by 1,970
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.815 · Cited by 792
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Food, gastrointestinal pH, and models of oral drug absorption
Abuhelwa, A. Y., Williams, D. B., Upton, R. N., & Foster, D. J. R. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.034 · Cited by 349
The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043005001 · Cited by 315
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
Müller, J., Lips, K. S., Metzner, L., Neubert, R. H. H., Koepsell, H., & Brandsch, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.011 · Cited by 262
Self-citationMammalian peptide transporters as targets for drug delivery
Rubio-Aliaga, I., & Daniel, H. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02072-2 · Cited by 240
Peptide transporters and their roles in physiological processes and drug disposition
Rubio-Aliaga, I., & Daniel, H. (2008) · Xenobiotica · doi:10.1080/00498250701875254 · Cited by 238
Pharmaceutical and pharmacological importance of peptide transporters
Brandsch, M., Knütter, I., & Bosse-Doenecke, E. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0002 · Cited by 221
Self-citationPharmacokinetics in Drug Discovery
Ruiz-Garcia, A., Bermejo, M., Moss, A., & Casabo, V. G. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21009 · Cited by 199
Mechanistic Approaches to Predicting Oral Drug Absorption
Huang, W., Lee, S. L., & Yu, L. X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9098-z · Cited by 181
Papich, M. G., & Martinez, M. N. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9743-7 · Cited by 181
Shan, W., Zhu, X., Tao, W., Cui, Y., Liu, M., Wu, L., Li, L., Zheng, Y., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08183 · Cited by 180
β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter
Ganapathy, M. E., Huang, W., Rajan, D. P., Carter, A. L., Sugawara, M., Iseki, K., Leibach, F. H., & Ganapathy, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1699 · Cited by 175
Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
Pennick (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s9749 · Cited by 170
Optimized conditions of bio-mimetic artificial membrane permeation assay
Sugano, K., Hamada, H., Machida, M., Ushio, H., Saitoh, K., & Terada, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00845-6 · Cited by 164
Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting
Li, F., Maag, H., & Alfredson, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21047 · Cited by 162
Orally Active Peptides: Is There a Magic Bullet?
Räder, A. F. B., Weinmüller, M., Reichart, F., Schumacher‐Klinger, A., Merzbach, S., Gilon, C., Hoffman, A., & Kessler, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807298 · Cited by 161
Sugano, K., Takata, N., Machida, M., Saitoh, K., & Terada, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00240-5 · Cited by 154
Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption
Steffansen, B., Nielsen, C. U., Brodin, B., Eriksson, A. H., Andersen, R., & Frøkjær, S. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.10.010 · Cited by 153
Transport of Peptidomimetic Drugs by the Intestinal Di/tri‐peptide Transporter, PepT1
Brodin, B., Nielsen, C. U., Steffansen, B., & Frøkjær, S. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900601.x · Cited by 145
Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1
Groneberg, D. A., Döring, F., Eynott, P. R., Fischer, A., & Daniel, H. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g697 · Cited by 142
Targeting Intestinal Transporters for Optimizing Oral Drug Absorption
Varma, M. V. S., Ambler, C. M., Ullah, M., Rotter, C. J., Sun, H., Litchfield, J., Fenner, K. S., & El‐Kattan, A. F. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328850 · Cited by 138
The intestinal H+/peptide symporter PEPT1: structure–affinity relationships
Brandsch, M., Knütter, I., & Leibach, F. H. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00142-8 · Cited by 135
Self-citationZaki, N. M., & Hafez, M. M. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9758-7 · Cited by 131
Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity
Hagos, Y., & Wolff, N. A. (2010) · Toxins · doi:10.3390/toxins2082055 · Cited by 129
Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability
El‐Kattan, A. F., & Varm, M. (2012) · InTech eBooks · doi:10.5772/31087 · Cited by 123
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls
Brandsch, M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903042292 · Cited by 123
Self-citationThe renal type H+/peptide symporter PEPT2: structure-affinity relationships
Biegel, A., Knütter, I., Hartrodt, B., Gebauer, S., Theis, S., Luckner, P., Kottra, G., Rastetter, M., Zebisch, K., Thondorf, I., et al. (2006) · Amino Acids · doi:10.1007/s00726-006-0331-0 · Cited by 112
Self-citationBambeke, F. V., Michot, J.-M., & Tulkens, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg225 · Cited by 112
Luckner, P., & Brandsch, M. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.008 · Cited by 108
Self-citationTsume, Y., & Amidon, G. L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100053q · Cited by 103
Transport of Angiotensin-Converting Enzyme Inhibitors by H+/Peptide Transporters Revisited
Knütter, I., Wollesky, C., Kottra, G., Hahn, M. G., Fischer, W., Zebisch, K., Neubert, R. H. H., Daniel, H., & Brandsch, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143339 · Cited by 100
Self-citationDrugdrug interactions involving membrane transporters in the human kidney
Li, M., Anderson, G. D., & Wang, J. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.4.505 · Cited by 99
Spanier, B., & Rohm, F. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170038 · Cited by 97
Grunwald, S., Krause, R., Bruch, M., Henle, T., & Brandsch, M. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061793 · Cited by 97
Self-citationPaxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 96
Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins
Lu, X., Chan, T., Xu, C., Zhu, L., Zhou, Q. T., Roberts, K. D., Chan, H., Li, J., & Zhou, F. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv340 · Cited by 91
Transport of Free and Peptide-Bound Pyrraline at Intestinal and Renal Epithelial Cells
Hellwig, M., Geißler, S., Peto, A., Knütter, I., Brandsch, M., & Henle, T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901224p · Cited by 87
Self-citationNeumaier, F., Zlatopolskiy, B. D., & Neumaier, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101542 · Cited by 86
Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes
Choi, S.-W., Lee, M., Shiu, A. L., Yo, S. J., & Aponte, G. W. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00295.2006 · Cited by 86
Sala‐Rabanal, M., Loo, D. D. F., Hirayama, B. A., Turk, E., & Wright, E. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.107904 · Cited by 84
Theoretical Predictions of Drug Absorption in Drug Discovery and Development
Stenberg, P., m, C. A. S. B., Luthman, K., & Artursson, P. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00005 · Cited by 81
Biegel, A., Gebauer, S., Hartrodt, B., Brandsch, M., Neubert, K., & Thondorf, I. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048982w · Cited by 81
Self-citationModeling of active transport systems
Zhang, E. Y., Phelps, M. A., Chang, C. K., Ekins, S., & Swaan, P. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00007-8 · Cited by 80
Prodrugs and nanomicelles to overcome ocular barriers for drug penetration
Gote, V., Michael, A., & Pal, D. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1803278 · Cited by 79
Pharmacokinetic considerations in Roux-en-Y gastric bypass patients
Smith, A. N., Henriksen, B. S., & Cohen, A. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100630 · Cited by 77
INTERACTIONS OF AMOXICILLIN AND CEFACLOR WITH HUMAN RENAL ORGANIC ANION AND PEPTIDE TRANSPORTERS
Li, M., Anderson, G. D., Phillips, B., Kong, W., Shen, D. D., & Wang, J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006791 · Cited by 77
Zhang, E. Y., Knipp, G. T., Ekins, S., & Swaan, P. W. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120015692 · Cited by 76
Hutson, P. H., Pennick, M., & Secker, R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.014 · Cited by 72
The oligopeptide transporter hPepT1: gateway to the innate immune response
Charrier, L., & Merlin, D. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700423 · Cited by 71
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Dalmasso, G., Nguyen, H. T. T., Ingersoll, S. A., Ayyadurai, S., Laroui, H., Charania, M. A., Yan, Y., Sitaraman, S. V., & Merlin, D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.080 · Cited by 69
Nielsen, C. U., Andersen, R., Brodin, B., Frøkjær, S., Taub, M. E., & Steffansen, B. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00427-8 · Cited by 67
Pharmacokinetic Interaction between JBP485 and Cephalexin in Rats
Zhang, J., Wang, C., Liu, Q., Meng, Q., Cang, J., Sun, H., Gao, Y., Kaku, T., & Liu, K. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032060 · Cited by 66
Arafat, M., Kirchhoefer, C., Mikov, M., Sarfraz, M., & Löbenberg, R. (2017) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3ck88 · Cited by 64
Harder, D., Stolz, J., Casagrande, F., Obrdlik, P., Weitz, D., Fotiadis, D., & Daniel, H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06477.x · Cited by 64
Chu, X.-Y., Sánchez-Castaño, G. P., Higaki, K., Oh, D. M., Hsu, C., & Amidon, G. L. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29265-x · Cited by 64
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Amoxicillin Trihydrate
Thambavita, D., Galappatthy, P., Mannapperuma, U., Jayakody, L., Cristofoletti, R., Abrahamsson, B., Groot, D. W., Langguth, P., Mehta, M., Parr, A. F., et al. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.068 · Cited by 63
In Vitro and Pharmacophore-Based Discovery of Novel hPEPT1 Inhibitors
Ekins, S., Johnston, J. S., Bahadduri, P. M., D’Souza, V. M., Ray, A., Chang, C. K., & Swaan, P. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2505-y · Cited by 63
Gebauer, S., Knütter, I., Hartrodt, B., Brandsch, M., Neubert, K., & Thondorf, I. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030976x · Cited by 62
Self-citationBeale, J. H., Parker, J. L., Samsudin, F., Barrett, A. L., Senan, A., Bird, L. E., Scott, D. J., Owens, R. J., Sansom, M. S. P., Tucker, S. J., et al. (2015) · Structure · doi:10.1016/j.str.2015.07.016 · Cited by 61
A Novel Inhibitor of the Mammalian Peptide Transporter PEPT1
Knütter, I., Theis, S., Hartrodt, B., Born, I., Brandsch, M., Daniel, H., & Neubert, K. (2001) · Biochemistry · doi:10.1021/bi0026371 · Cited by 61
Self-citationUchida, Y., Ohtsuki, S., Kamiie, J., Ohmine, K., Iwase, R., & Terasaki, T. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.11.002 · Cited by 57
Suitability of RPMI 2650 cell models for nasal drug permeability prediction
Sibinovska, N., Žakelj, S., & Kristan, K. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.10.008 · Cited by 55
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria
Darlow, C. A., da Costa, R. M. A., Ellis, S., Franceschi, F. J., Sharland, M., Piddock, L. J. V., Das, S., & Hope, W. W. (2021) · Pediatric Drugs · doi:10.1007/s40272-021-00465-z · Cited by 55
δ‐Aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1)
Frølund, S. U., Marquez, O., Larsen, M., Brodin, B., & Nielsen, C. U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00620.x · Cited by 55
Kotecha, J., Shah, S. A., Rathod, I. S., & Subbaiah, G. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.025 · Cited by 52
Human peptide transporters: therapeutic applications
Nielsen, C. U., Brodin, B., Jørgensen, F. S., Frøkjær, S., & Steffansen, B. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.9.1329 · Cited by 52
Uptake, Transport and Regulation of JBP485 by PEPT1 in vitro and in vivo
Liu, Z., Wang, C., Liu, Q., Meng, Q., Cang, J., Mei, L., Kaku, T., & Liu, K. (2011) · Peptides · doi:10.1016/j.peptides.2011.01.019 · Cited by 50
Wenzel, U., Kuntz, S., Diestel, S., & Daniel, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1375-1380.2002 · Cited by 50
Smith, P. W., Zuccotto, F., Bates, R. H., Martínez, M. S., Read, K. D., Peet, C. F., & Epemolu, O. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00160 · Cited by 49
Metzner, L., Kalbitz, J., & Brandsch, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059014 · Cited by 48
Self-citationSibinovska, N., Žakelj, S., Roškar, R., & Kristan, K. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119484 · Cited by 47
Classification Structure-Activity Relations (C-SAR) in Prediction of Human Intestinal Absorption
Zmuidinavicius, D., Didžiapetris, R., Japertas, P., Avdeef, A., & Petrauskas, A. A. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10321 · Cited by 47
A Novel High-Throughput PepT1 Transporter Assay Differentiates between Substrates and Antagonists
Faria, T. N., Timoszyk, J. K., Stouch, T. R., Vig, B. S., Landowski, C. P., Amidon, G. L., Weaver, C. D., Wall, D. A., & Smith, R. L. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034001k · Cited by 46
Bravo, S. A., Nielsen, C. U., Amstrup, J., Frøkjær, S., & Brodin, B. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00205-7 · Cited by 46
Repurposing Salicylamide for Combating Multidrug-Resistant Neisseria gonorrhoeae
Alhashimi, M., Mayhoub, A. S., & Seleem, M. N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01225-19 · Cited by 45
Flaten, G. E., Kottra, G., Stensen, W., Isaksen, G. V., Karstad, R., Svendsen, J. S. M., Daniel, H., & Svenson, J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1015704 · Cited by 43
Jarc, T., Novak, M., Hevir, N., Rižner, T. L., Kreft, M. E., & Kristan, K. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13111 · Cited by 42
Ayyadurai, S., Charania, M. A., Xiao, B., Viennois, É., & Merlin, D. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.77 · Cited by 42
Våbenø, J., Nielsen, C. U., Ingebrigtsen, T., Lejon, T., Steffansen, B., & Luthman, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040780c · Cited by 42
Neumann, J., Bruch, M., Gebauer, S., & Brandsch, M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04114.x · Cited by 41
Self-citationVåbenø, J., Lejon, T., Nielsen, C. U., Steffansen, B., Chen, W., Ouyang, H. X., Borchardt, R. T., & Luthman, K. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031022+ · Cited by 41
Linnankoski, J., Ranta, V., Yliperttula, M. L., & Urtti, A. O. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.03.001 · Cited by 40
Larder, C. E., Iskandar, M. M., & Kubow, S. J. (2023) · Medicines · doi:10.3390/medicines10090050 · Cited by 38
Fischer, W., Praetor, K., Metzner, L., Neubert, R. H. H., & Brandsch, M. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.022 · Cited by 37
Self-citationRelevance of PepT1 in the Intestinal Permeability and Oral Absorption of Cefadroxil
Posada, M. M., & Smith, D. E. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0937-8 · Cited by 37
Use of the Øie-Tozer Model in Understanding Mechanisms and Determinants of Drug Distribution
Waters, N. J., & Lombardo, F. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032458 · Cited by 37
Grumetto, L., Russo, G., & Barbato, F. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.019 · Cited by 37
Moore, V., Irwin, W. J., Timmins, P., Lambert, P. A., Chong, S., Dando, S. A., & Morrison, R. A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00564-0 · Cited by 37
Nielsen, C. U., Amstrup, J., Nielsen, R., Steffansen, B., Frøkjær, S., & Brodin, B. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01113.x · Cited by 37
Pichichero, M. E., & Reed, M. D. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911040-00003 · Cited by 36
Tsuji, A. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0478-3 · Cited by 36
Biegel, A., Gebauer, S., Brandsch, M., Neubert, K., & Thondorf, I. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601811 · Cited by 35
Self-citationStauffer, M., Jeckelmann, J.-M., İlgü, H., Ucurum, Z., Boggavarapu, R., & Fotiadis, D. (2022) · Communications Chemistry · doi:10.1038/s42004-022-00636-0 · Cited by 34
Grumetto, L., Russo, G., & Barbato, F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.062 · Cited by 34
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter
Lafforgue, G., Arellano, C., Vachoux, C., Woodley, J. F., Philibert, C., Dupouy, V., Bousquet‐mélou, A., Gandia, P., & Houin, G. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00572.x · Cited by 34
Maeng, H., Durk, M. R., Chow, E. C. Y., Ghoneim, R. H., & Pang, K. S. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.742 · Cited by 33
Malabsorption of Oral Antibiotics in Pregnancy after Gastric Bypass Surgery
Magee, S. R., Shih, G., & Hume, A. (2007) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2007.03.060177 · Cited by 33
Metadata
- Authors
- Bretschneider, B., Brandsch, M., & Neubert, R.
- Affiliations
- Martin Luther University Halle-Wittenberg (DE)
- Corresponding author
- Neubert, Reinhard
- ORCID
- Neubert, Reinhard
- Venue
- Pharmaceutical Research
- Published
- 1999-01
- Volume
- 16
- Issue
- 1
- Pages
- 55-61
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2004475083
- Cited by
- 202
- References
- 27
- Citations by year
- 2026: 2 · 2024: 7 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 7
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- beta-lactam antibiotics, intestinal absorption, PepT1, Caco-2 cell monolayers, transepithelial flux, oral bioavailability, binding affinity, cefuroxime axetil, ceftriaxone, cefotaxime, cefradine, ampicillin
- MeSH terms
- Peptide Transporter 1, Administration, Oral, Anti-Bacterial Agents, Biological Availability, Biological Transport, Carrier Proteins, Dipeptides, Epithelial Cells, Humans, Intestinal Mucosa, Caco-2 Cells, Symporters, beta-Lactams
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.